问题从来不是是否全面提价。而是哪些 ACV 群体在净收入留存上有空间，下次续约或扩展能提升多少，以及提价会损失多少 land-and-expand 收入。 B2B SaaS 公司面临更难的结构性问题：增长已从 42% 降至 32%，而 60% 的收入集中在经济效益最差的细分市场。因此任何可信的答案都必须同时考虑净收入留存和 CAC 回本期，而这正是大多数内部分析停止的地方，因为两者存在于不同系统中。
问题从来不是是否全面提价。而是哪些 ACV 群体在净收入留存上有空间，下次续约或扩展能提升多少，以及提价会损失多少 land-and-expand 收入。 B2B SaaS 公司面临更难的结构性问题：增长已从 42% 降至 32%，而 60% 的收入集中在经济效益最差的细分市场。因此任何可信的答案都必须同时考虑净收入留存和 CAC 回本期，而这正是大多数内部分析停止的地方，因为两者存在于不同系统中。
ACV 调整无需新 logo 或招聘即可体现在下一次续约或扩展发票上。年经常性收入达到 $45M ARR、拥有 280 名工程师的创始人仍回避这些调整，因为对净收入留存和 CAC 回本期的影响只有事后才会显现，因此定价过低的细分市场持续存在，而增长从 42% 滑落到 32%。
所需的分析按 ACV 细分市场和毛利贡献拆分基础，而不是给出一个单一目标价格。它显示哪些账户以远高于当前 ACV 的水平续约和扩展，哪些已达到天花板，以及哪些续约受临时折扣而非公开阶梯价格影响。
任何有效的 ACV 调整都会以失去部分账户为代价。当净收入留存在调整后保持不变时，提价就在本可承受更多提价的细分市场中留下了可得收入。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 几乎所有续约和扩展都按报价 ACV 成交，客户对价格几乎没有异议。
✓ 大多数大额 ACV 交易都出现折扣，且折扣幅度因销售代表而异，而非按细分市场规则执行。
✓ 目录价格和续约提价保持不变，而最弱细分市场中的 60% 收入持续拖累净收入留存。
通常会让情况更糟的做法。 对所有续约和扩展应用相同百分比的提价，这进一步压缩了价格敏感细分市场，同时仍在按价值而非价格扩展的账户中留下空间。
It is for you if you run or finance a B2B SaaS company and almost every deal closes, and closes quickly. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家 B2B SaaS 公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Cost Reduction & Efficiency · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 定价与收入优化, one of 29 engagements the platform runs. For B2B SaaS 公司 it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
没有通用答案，有用的分析是按细分市场进行的。可以确定的是，你担心的流失通常集中在这样一个群体：失去他们反而会改善你的经济效益。
先对新客户提价更安全也更慢；现有客户才是收入所在。合理的顺序是先调整新客户定价，观察一个季度的成交率，然后在续约时通知现有客户提价。
那么你在用价格之外的因素与他们竞争，或者你没有——这才是真正的问题。在没有成本结构支撑的情况下靠价格竞争，是以不断扩大的销量亏钱的可靠方式。
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית